InBody Co.,Ltd (KOSDAQ:041830)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,900
+300 (1.27%)
May 13, 2025, 3:30 PM KST
-14.18%
Market Cap 302.74B
Revenue (ttm) 204.46B
Net Income (ttm) 33.14B
Shares Out 12.67M
EPS (ttm) 2,557.47
PE Ratio 9.35
Forward PE 8.95
Dividend 400.00 (1.69%)
Ex-Dividend Date Mar 28, 2025
Volume 19,482
Average Volume 32,018
Open 23,600
Previous Close 23,600
Day's Range 23,400 - 23,900
52-Week Range 20,700 - 29,300
Beta 0.43
RSI 53.98
Earnings Date May 8, 2025

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in bariatric, cardiology, diabetes, frailty and aging, ICU, lymphedema, nephrology, nutrition, oncology, sports medicine, and rehabilitation and physical therapy applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 312
Stock Exchange KOSDAQ
Ticker Symbol 041830
Full Company Profile

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.

Financial Statements

News

There is no news available yet.